Revvity, Inc. (NYSE:RVTY) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Revvity, Inc. (NYSE:RVTY - Free Report) by 15.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 792,683 shares of the company's stock after purchasing an additional 108,605 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.65% of Revvity worth $88,471,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of RVTY. HB Wealth Management LLC lifted its stake in shares of Revvity by 4.6% during the 4th quarter. HB Wealth Management LLC now owns 2,380 shares of the company's stock valued at $266,000 after buying an additional 104 shares in the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in Revvity by 55.9% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock valued at $43,000 after purchasing an additional 138 shares during the last quarter. Atomi Financial Group Inc. grew its holdings in Revvity by 8.8% during the 4th quarter. Atomi Financial Group Inc. now owns 1,861 shares of the company's stock valued at $208,000 after purchasing an additional 151 shares during the last quarter. Janney Montgomery Scott LLC grew its holdings in Revvity by 87.0% during the 4th quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company's stock valued at $881,000 after purchasing an additional 3,672 shares during the last quarter. Finally, Fifth Third Bancorp grew its holdings in Revvity by 9.6% during the 4th quarter. Fifth Third Bancorp now owns 5,362 shares of the company's stock valued at $598,000 after purchasing an additional 469 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently commented on RVTY shares. Raymond James reiterated an "outperform" rating and set a $120.00 price target (down from $145.00) on shares of Revvity in a report on Tuesday, April 29th. Wall Street Zen cut shares of Revvity from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Barclays lowered their price objective on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. JPMorgan Chase & Co. lowered their price objective on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research report on Tuesday, April 29th. Finally, UBS Group raised shares of Revvity from a "neutral" rating to a "buy" rating and lowered their price objective for the company from $145.00 to $115.00 in a research report on Thursday, May 1st. Five investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Revvity currently has an average rating of "Moderate Buy" and a consensus price target of $125.64.

Revvity Stock Performance

Shares of NYSE:RVTY traded down $1.29 during midday trading on Friday, reaching $90.62. The company's stock had a trading volume of 195,470 shares, compared to its average volume of 951,887. The firm has a market capitalization of $10.68 billion, a PE ratio of 41.20, a P/E/G ratio of 3.82 and a beta of 1.02. Revvity, Inc. has a twelve month low of $88.01 and a twelve month high of $129.50. The stock has a fifty day moving average of $95.35 and a 200 day moving average of $108.44. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41.

Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.05. The business had revenue of $664.76 million for the quarter, compared to the consensus estimate of $662.30 million. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The company's revenue was up 2.3% compared to the same quarter last year. During the same period last year, the firm posted $0.98 earnings per share. On average, equities analysts expect that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.31%. The ex-dividend date is Friday, July 18th. Revvity's payout ratio is currently 11.91%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.